Trades on 1 secondary market

TenSixteen Bio

TenSixteen Bio is a San Francisco-based clinical-stage biotechnology company pioneering the study of somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics for age-related diseases including cancer and cardiovascular disease. Founded b

minimal 7.7 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Precision Medicine Genomics Clonal Hematopoiesis

TenSixteen Bio is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.